Innovate TED

A Multidisciplinary Thyroid Eye Disease Symposium

April 19-21, 2024 | Napa, CA


As our knowledge of Thyroid Eye Disease (TED) pathogenesis has advanced in recent years, with the delineation of the inflammatory pathways activated in the orbit as well as the critical role of insulin-growth factor I on the orbital fibroblast of TED patients, we have had a significant expansion of therapeutic options, as well as a continued interest in the development of novel therapies for this debilitating disease. The goal of Innovate TED will be to educate attendees with the most up-to-date developments in the field, encourage discussions across our disciplines, promote exchange of knowledge, enhance collaboration, celebrate the multidisciplinary care of TED patients, and stimulate further innovation in TED therapies.

Learning Objectives

At the conclusion of this activity, participants should be able to:

  • Discuss the latest advances in the understanding of the molecular pathogenesis TED
  • Link the mechanism of TED to potential therapeutic targets
  • Describe molecular targets, efficacy, and safety of new and emerging TED therapies
  • Implement strategies to personalize treatment of patients with TED based on patient characteristics and risk of adverse events
  • Detail the benefits interdisciplinary care for TED, including co-management strategies for endocrinologists and ophthalmologists

Target course participants include ophthalmologists, oculoplastic surgeons, endocrinologists, optometrists, trainees in these fields, primary care providers, patient advocates, and advanced practice providers involved in the care of patients with thyroid eye disease (TED). This inclusivity shows a commitment to spreading knowledge and awareness across all stakeholders involved in the care of patients with TED.